Humana Inc. $HUM Stock: Intech Investment Management LLC Grows Stake

Intech Investment Management LLC raised its position in Humana Inc. (NYSE:HUM – Free Report) by 325.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,925 shares of the insurance provider’s stock after buying an additional 12,950 shares during the quarter. Intech Investment Management LLC’s holdings in Humana were worth $6,458,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Silver Oak Securities Incorporated lifted its holdings in shares of Humana by 46.5% during the third quarter. Silver Oak Securities Incorporated now owns 646 shares of the insurance provider’s stock worth $246,000 after buying an additional 205 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Humana by 28.7% in the third quarter. Bessemer Group Inc. now owns 2,657 shares of the insurance provider’s stock valued at $1,014,000 after acquiring an additional 593 shares during the period. Hantz Financial Services Inc. grew its stake in shares of Humana by 555.4% in the third quarter. Hantz Financial Services Inc. now owns 10,552 shares of the insurance provider’s stock valued at $4,026,000 after acquiring an additional 8,942 shares in the last quarter. Diversified Trust Co grew its stake in shares of Humana by 23.2% in the third quarter. Diversified Trust Co now owns 4,041 shares of the insurance provider’s stock valued at $1,542,000 after acquiring an additional 760 shares in the last quarter. Finally, Moors & Cabot Inc. grew its stake in shares of Humana by 4.3% in the third quarter. Moors & Cabot Inc. now owns 804 shares of the insurance provider’s stock valued at $307,000 after acquiring an additional 33 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

HUM opened at $442.84 on Wednesday. The firm has a market cap of $53.19 billion, a P/E ratio of 34.78, a price-to-earnings-growth ratio of 2.20 and a beta of 0.65. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $462.87. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.65 and a current ratio of 1.65. The business’s fifty day moving average is $410.55 and its 200-day moving average is $319.48.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.30. The company had revenue of $41.16 billion for the quarter, compared to analysts’ expectations of $40.87 billion. Humana had a return on equity of 8.50% and a net margin of 0.81%. Humana’s revenue was up 26.1% on a year-over-year basis. During the same quarter last year, the business earned $3.24 earnings per share. Humana has set its FY 2026 guidance at 9.500- EPS. Sell-side analysts expect that Humana Inc. will post 9.66 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be paid a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Thursday, December 24th. Humana’s dividend payout ratio is presently 34.44%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on HUM shares. Truist Financial raised their price target on shares of Humana from $415.00 to $475.00 and gave the stock a “hold” rating in a research report on Monday, October 12th. Sanford C. Bernstein reissued an “outperform” rating and issued a $515.00 price objective on shares of Humana in a report on Tuesday. Wolfe Research restated an “outperform” rating and set a $450.00 target price on shares of Humana in a research report on Monday, August 24th. Lake Street Capital assumed coverage on shares of Humana in a report on Thursday, July 30th. They set a “buy” rating on the stock. Finally, Morgan Stanley raised shares of Humana from an “underweight” rating to an “overweight” rating in a report on Friday, October 9th. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $484.78.

Read Our Latest Analysis on HUM

Key Headlines Impacting Humana

These are some of the HUM headlines that stood out recently:

Insider Buying and Selling

In other Humana news, insider Joseph Ventura sold 5,495 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $433.85, for a total value of $2,384,005.75. Following the transaction, the insider directly owned 21,910 shares of the company’s stock, valued at $9,505,653.50. This trade represents a 20.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.20% of the stock is currently owned by corporate insiders.

Humana Company Profile

(Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Featured Articles

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.